Goodman Ingrid Henrietta
Department of Medicine, Veterinary Specialist Services, Underwood, Queensland, Australia.
J Vet Emerg Crit Care (San Antonio). 2020 Jan;30(1):74-80. doi: 10.1111/vec.12919. Epub 2019 Dec 28.
To describe the treatment and clinical course of a dog accidentally prescribed 10 times the recommended dose of colchicine (0.3 mg/kg/d instead of 0.03 mg/kg/d).
After glaucoma surgery, a 1-year-old male neutered Pomeranian weighing 6.8 kg was prescribed 1,000 μg colchicine twice a day per os. The dog presented to the emergency department after the first dose with vomiting and was treated as an outpatient. Two colchicine doses later, the dog represented with vomiting, ocular pain, and increased intraocular pressure. The dog's vital signs were normal, and the dog was admitted for rehydration, analgesia, and revision glaucoma surgery the next day. Two hours after revision surgery, the dog developed vomiting and diarrhea. Postoperatively, the dog was hypothermic (36.3°C), persistently hypertensive (227 mm Hg), and bradycardic (60/min). Biochemistry revealed metabolic acidosis and increased hepatic enzyme activities. Mannitol was administered for presumed cerebral edema. Later, the dog developed bradycardia due to second-degree atrioventricular heart block, which responded to atropine. Total hospitalization was 9 days. Treatment included IV fluids, IV lipid emulsion, N-acetylcysteine, activated charcoal, gastroprotectants, antiemetics, opioids, antimicrobials, and barrier nursing due to transient neutropenia.
This is the first report to describe the successful treatment of a dog with colchicine overdose. The systemic effects were presumed to be secondary to colchicine toxicosis rather than diet, infection, or other drug reaction, and may have been compounded by a second anesthetic episode. Gastrointestinal signs, symptoms of cerebral edema, cardiac arrhythmias, and neutropenia were documented. One other report of colchicine overdose in a dog exists, and that patient was euthanized. This report demonstrates that complete recovery with intensive care is possible; however, the prognosis remains guarded.
描述一只意外服用了推荐剂量10倍秋水仙碱(0.3毫克/千克/天而非0.03毫克/千克/天)的犬的治疗及临床过程。
一只1岁、体重6.8千克的雄性去势博美犬在青光眼手术后,口服给予秋水仙碱1000微克,每日两次。首次给药后该犬出现呕吐并前往急诊科就诊,之后作为门诊患者接受治疗。在服用两次秋水仙碱后,该犬再次出现呕吐、眼痛和眼压升高。该犬生命体征正常,次日入院接受补液、镇痛及青光眼修复手术。修复手术后两小时,该犬出现呕吐和腹泻。术后,该犬体温过低(36.3℃)、持续高血压(227毫米汞柱)且心动过缓(60次/分钟)。生化检查显示代谢性酸中毒及肝酶活性升高。因推测有脑水肿而给予甘露醇治疗。之后,该犬因二度房室传导阻滞出现心动过缓,对阿托品治疗有反应。总住院时间为9天。治疗包括静脉输液、静脉注射脂质乳剂、N - 乙酰半胱氨酸、活性炭、胃黏膜保护剂(胃保护剂)、止吐药、阿片类药物、抗菌药物,以及因短暂性中性粒细胞减少而采取的隔离护理。
这是第一份描述成功治疗秋水仙碱过量犬的报告。全身效应被推测继发于秋水仙碱中毒而非饮食、感染或其他药物反应,且可能因第二次麻醉事件而加重。记录了胃肠道症状、脑水肿症状、心律失常和中性粒细胞减少。另有一份犬秋水仙碱过量的报告,该病例的犬被实施了安乐死。本报告表明,通过重症监护有可能实现完全康复;然而,预后仍不容乐观。